Andrew P. Zappia is a partner in the Health Sciences Department of Pepper Hamilton LLP, and is resident in the Rochester and New York offices. He is the partner in charge of the firm’s Rochester office. Mr. Zappia has represented a wide variety of technology companies in intellectual property disputes and licensing, joint development, and commercial transactions, including trials and arbitrations relating to pharmaceuticals, biologics, medical devices, mechanical inventions and software. He is experienced in the full array of issues that arise in connection with intellectual property licensing and disputes, including patent, trademark, and copyright protection and infringement; International Trade Commission proceedings; antitrust issues; and trade secret and trade dress protection and disputes.
Mr. Zappia has an active abbreviated new drug application (ANDA) patent litigation practice. He has served as lead counsel in more than a dozen ANDA litigations in the United States and has coordinated international pharmaceutical patent enforcement strategies in Europe, Canada, India, Japan, New Zealand and Australia. Many of these cases have involved billion-dollar drug products, and he has worked with internationally renowned experts, conducted Markman hearings and trials, and consulted with clients on antitrust, FDA and settlement strategies.
Mr. Zappia also has an active licensing and litigation practice concerning trademarks, trade secrets and copyrights. He has represented dozens of technology, franchise and distribution companies in a wide range of areas, including business formation, regulatory and disclosure practice, dispute resolution, litigation and arbitration work. Mr. Zappia has represented numerous national technology and franchise companies in dozens of litigations and arbitrations on issues such as trademark/copyright infringement, trade secret misappropriation, sales fraud, distribution disputes, encroachment, implied covenant claims and antitrust disputes.
Before joining Pepper, Mr. Zappia was an equity partner at Nixon Peabody LLP and LeClairRyan PLLC.